Relationship Between Thyroid Hormone and Liver Steatosis Analysis Parameter in Obese Participants: A Case-Control Study

References

• Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328–357. doi:10.1002/hep.29367
   PubMed Web of Science ®Google Scholar
• Estes C, Anstee QM, Arias-Loste MT, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030. J Hepatol. 2018;69(4):896–904. doi:10.1016/j.jhep.2018.05.036
   PubMed Web of Science ®Google Scholar
• Brunt EM, Kleiner DE, Carpenter DH, et al. NAFLD: reporting histologic findings in clinical practice. Hepatology. 2021;73(5):2028–2038. doi:10.1002/hep.31599
   Web of Science ®Google Scholar
• Fan JG, Kim SU, Wong VW. New trends on obesity and NAFLD in Asia. J Hepatol. 2017;67(4):862–873. doi:10.1016/j.jhep.2017.06.003
   PubMed Web of Science ®Google Scholar
• Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology. 2020;158(7):1851–1864. doi:10.1053/j.gastro.2020.01.052
   PubMed Web of Science ®Google Scholar
• Cariou B, Byrne CD, Loomba R, Sanyal AJ. Nonalcoholic fatty liver disease as a metabolic disease in humans: a literature review. Diabetes Obes Metab. 2021;23(5):1069–1083. doi:10.1111/dom.14322
   Web of Science ®Google Scholar
• Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202–209. doi:10.1016/j.jhep.2020.03.039
   PubMed Web of Science ®Google Scholar
• Li Q, Dhyani M, Grajo JR, Sirlin C, Samir AE. Current status of imaging in nonalcoholic fatty liver disease. World J Hepatol. 2018;10(8):530–542. doi:10.4254/wjh.v10.i8.530
   PubMed Web of Science ®Google Scholar
• De Sousa Magalhães R, Xavier S, Magalhães J, Rosa B, Marinho C, Cotter J. Transient elastography through controlled attenuated parameter assisting the stratification of cardiovascular disease risk in NAFLD patients. Clin Res Hepatol Gastroenterol. 2021;45(5):101580. doi:10.1016/j.clinre.2020.11.010
   Web of Science ®Google Scholar
• Zhang X, Heredia NI, Balakrishnan M, Thrift AP. Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: results from NHANES 2017–2018. PLoS One. 2021;16(6):e0252164. doi:10.1371/journal.pone.0252164
   PubMed Web of Science ®Google Scholar
• Ren X, Xia S, Zhang L, et al. Analysis of liver steatosis analysis and controlled attenuation parameter for grading liver steatosis in patients with chronic hepatitis B. Quant Imaging Med Surg. 2021;11(2):571–578. doi:10.21037/qims-19-1091
   Web of Science ®Google Scholar
• Sasso M, Beaugrand M, de Ledinghen V, et al. Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol. 2010;36(11):1825–1835. doi:10.1016/j.ultrasmedbio.2010.07.005
   PubMed Web of Science ®Google Scholar
• Sinha RA, Bruinstroop E, Singh BK, Yen PM. Nonalcoholic fatty liver disease and hypercholesterolemia: roles of thyroid hormones, metabolites, and agonists. Thyroid. 2019;29(9):1173–1191. doi:10.1089/thy.2018.0664
   PubMed Web of Science ®Google Scholar
• Ritter MJ, Amano I, Hollenberg AN. Thyroid hormone signaling and the liver. Hepatology. 2020;72(2):742–752. doi:10.1002/hep.31296
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang W, Yu X, Qi X. Thyroid function and risk of non-alcoholic fatty liver disease in euthyroid subjects. Ann Hepatol. 2018;17(5):779–788. doi:10.5604/01.3001.0012.3136
   Web of Science ®Google Scholar
• Jin Y, Zhou Y, Wang X, et al. Association between thyroid hormones and visceral fat area in the patients with type 2 diabetes. Chi J Endocrinol Metab. 2020;(02):116–117-118-119. doi:10.3760/cma.j.issn.1000-6699.2020.02.005
   Google Scholar
• Endocrinology Branch of the Chinese Medical Association, Diabetes Branch of Chinese Medical Association, Obesity and Diabetes Surgeons Committee of Surgeons Branch of Chinese Medical Doctor Association. Multidisciplinary clinical consensus on diagnosis and treatment of obesity (2021 edition). Chi J Digest Surg. 2021;20(11):1137–1152. doi:10.3760/cma.j.cn115610-20210829-00422
   Google Scholar
• Sasso M, Miette V, Sandrin L, Beaugrand M. The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan. Clin Res Hepatol Gastroenterol. 2012;36(1):13–20. doi:10.1016/j.clinre.2011.08.001
   PubMed Web of Science ®Google Scholar
• Knudsen N, Laurberg P, Rasmussen LB, et al. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab. 2005;90(7):4019–4024. doi:10.1210/jc.2004-2225
   PubMed Web of Science ®Google Scholar
• Motamed B, Eftekharzadeh A, Hosseinpanah F, Tohidi M, Hasheminia M, Azizi F. The relation between changes in thyroid function and anthropometric indices during long-term follow-up of euthyroid subjects: the Tehran Thyroid Study (TTS). Eur J Endocrinol. 2016;175(4):247–253. doi:10.1530/eje-16-0414
   Web of Science ®Google Scholar
• Shin JA, Mo EY, Kim ES, Moon SD, Han JH. Association between lower normal free thyroxine concentrations and obesity phenotype in healthy euthyroid subjects. Int J Endocrinol. 2014;2014:104318. doi:10.1155/2014/104318
   Web of Science ®Google Scholar
• Ren R, Jiang X, Zhang X, et al. Association between thyroid hormones and body fat in euthyroid subjects. Clin Endocrinol (Oxf). 2014;80(4):585–590. doi:10.1111/cen.12311
   PubMed Web of Science ®Google Scholar
• Roef GL, Rietzschel ER, Van Daele CM, et al. Triiodothyronine and free thyroxine levels are differentially associated with metabolic profile and adiposity-related cardiovascular risk markers in euthyroid middle-aged subjects. Thyroid. 2014;24(2):223–231. doi:10.1089/thy.2013.0314
   PubMed Web of Science ®Google Scholar
• Teixeira P, Dos Santos PB, Pazos-Moura CC. The role of thyroid hormone in metabolism and metabolic syndrome. Ther Adv Endocrinol Metab. 2020;11:2042018820917869. doi:10.1177/2042018820917869
   Web of Science ®Google Scholar
• Cabanelas A, Lisboa PC, Moura EG, Pazos-Moura CC. Acute effects of leptin on 5’-deiodinases are modulated by thyroid state of fed rats. Horm Metab Res. 2007;39(11):818–822. doi:10.1055/s-2007-991169
   Web of Science ®Google Scholar
• Macek Jílková Z, Pavelka S, Flachs P, Hensler M, Kůs V, Kopecký J. Modulation of type I iodothyronine 5’-deiodinase activity in white adipose tissue by nutrition: possible involvement of leptin. Physiol Res. 2010;59(4):561–569. doi:10.33549/physiolres.931866
   Web of Science ®Google Scholar
• Araujo RL, Andrade BM, Padrón AS, et al. High-fat diet increases thyrotropin and oxygen consumption without altering circulating 3,5,3’-triiodothyronine (T3) and thyroxine in rats: the role of iodothyronine deiodinases, reverse T3 production, and whole-body fat oxidation. Endocrinology. 2010;151(7):3460–3469. doi:10.1210/en.2010-0026
   Web of Science ®Google Scholar
• Roef G, Lapauw B, Goemaere S, et al. Body composition and metabolic parameters are associated with variation in thyroid hormone levels among euthyroid young men. Eur J Endocrinol. 2012;167(5):719–726. doi:10.1530/eje-12-0447
   PubMed Web of Science ®Google Scholar
• Younossi ZM. Non-alcoholic fatty liver disease - A global public health perspective. J Hepatol. 2019;70(3):531–544. doi:10.1016/j.jhep.2018.10.033
   PubMed Web of Science ®Google Scholar
• Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. Nat Rev Gastroenterol Hepatol. 2021;18(9):599–612. doi:10.1038/s41575-021-00448-y
   PubMed Web of Science ®Google Scholar
• Mantovani A, Scorletti E, Mosca A, Alisi A, Byrne CD, Targher G. Complications, morbidity and mortality of nonalcoholic fatty liver disease. Metabolism. 2020;111s:154170. doi:10.1016/j.metabol.2020.154170
   PubMed Web of Science ®Google Scholar
• van den Berg EH, van Tienhoven-wind LJ, Amini M, et al. Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study. Metabolism. 2017;67:62–71. doi:10.1016/j.metabol.2016.11.002
   PubMed Web of Science ®Google Scholar
• Liu G, Zheng X, Guan L, et al. Free triiodothyronine levels are positively associated with non-alcoholic fatty liver disease in euthyroid middle-aged subjects. Endocr Res. 2015;40(4):188–193. doi:10.3109/07435800.2014.987399
   PubMed Web of Science ®Google Scholar
• Ding WJ, Wang MM, Wang GS, Shen F, Qin JJ, Fan JG. Thyroid function is associated with non-alcoholic fatty liver disease in chronic hepatitis B-infected subjects. J Gastroenterol Hepatol. 2015;30(12):1753–1758. doi:10.1111/jgh.12998
   Web of Science ®Google Scholar
• Ma D, Zeng J, Huang B, et al. Independent associations of thyroid-related hormones with hepatic steatosis and insulin resistance in euthyroid overweight/obese Chinese adults. BMC Gastroenterol. 2021;21(1):431. doi:10.1186/s12876-021-02011-0
   Web of Science ®Google Scholar
• Xu C, Xu L, Yu C, Miao M, Li Y. Association between thyroid function and nonalcoholic fatty liver disease in euthyroid elderly Chinese. Clin Endocrinol (Oxf). 2011;75(2):240–246. doi:10.1111/j.1365-2265.2011.04016.x
   Web of Science ®Google Scholar
• Tao Y, Gu H, Wu J, Sui J. Thyroid function is associated with non-alcoholic fatty liver disease in euthyroid subjects. Endocr Res. 2015;40(2):74–78. doi:10.3109/07435800.2014.952014
   PubMed Web of Science ®Google Scholar